Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-11-22
2009-11-03
Landsman, Robert (Department: 1646)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
07612041
ABSTRACT:
In certain aspects, the present invention provides compositions and methods for promoting bone growth and increasing bone density.
REFERENCES:
patent: 4973577 (1990-11-01), Vale, Jr. et al.
patent: 5118667 (1992-06-01), Adams et al.
patent: 5885794 (1999-03-01), Mathews et al.
patent: 6093547 (2000-07-01), Jin et al.
patent: 6162896 (2000-12-01), Mathews et al.
patent: 6440930 (2002-08-01), Rinella, Jr.
patent: 6835544 (2004-12-01), Mathews et al.
patent: 2004/0197828 (2004-10-01), Gaddy
patent: WO-92/20793 (1992-11-01), None
patent: WO-02/43759 (2002-06-01), None
patent: WO-2004/039948 (2004-05-01), None
patent: WO-2005/028517 (2005-03-01), None
patent: WO-2005/094871 (2005-10-01), None
patent: WO-2005/097825 (2005-10-01), None
patent: WO-2006/012627 (2006-02-01), None
patent: WO-2006/039400 (2006-04-01), None
patent: WO-2007/062188 (2007-05-01), None
Mickle et al., Med. Clin. North Am., vol. 84(3), p. 597-607, 2000.
Harrison, et al., “Antagonists of Activin Signaling: Mechanisms and Potential Biological Applications,” Trends in Endocrinology and Metabolism, 16(2):73-78 (2005).
“Recombinant Human Activin RIIA/Fc Chimera,” R&D Systems 340-R2.
Centrella et al., “Activin-A Binding and Biochemical Effects in Osteoblast-Enriched Cultures from Fetal-Rat Parietal Bone,” Molecular and Cellular Biology, 11(1):250-58 (1991).
Daluiski et al., “Bone Morphogenetic Protein-3 is a Negative Regulator of Bone Density,” Nature Genetics, 27:84-88 (2001).
Donaldson et al., “Activin and Inhibin Binding to the Soluble Extracellular Domain of Activin Receptor II,” Endocrinology, 140(4):1760-1766 (1999).
Fuller et al., “Activin A Is an Essential Cofactor for Osteoclast Induction,” Biochemical and Biophysical Research Communications, 268:2-7 (2000).
Funaba et al., “Expression and Localization of Activin Receptors During Endochondral Bone Development,” European Journal of Endocrinology, 144:63-71 (2001).
Gaddy-Kurten et al., “Inhibin Suppresses and Activin Stimulates Osteoblastogenesis and Osteoclastogenesis in Murine Bone Marrow Cultures,” Endocrinology, 143(1):74-83 (2002).
Gamer et al., “BMP-3 is a Novel Inhibitor of Both Activin and BMP-4 Signaling in Xenopus Embryos,” Developmental Biology, 285:156-168 (2005).
Hamrick et al., “Bone Mineral Content and Density in the Humerus of Adult Myostatin-Deficient Mice,” Calcified Tissue International, 71:63-68 (2002).
Hamrick, “Increased Bone Mineral Density in the Femora of GDF8 Knockout Mice,” The Anatomical Record, Part A 272A:388-391 (2003).
Hashimoto et al., “Functional Regulation of Osteoblastic Cells by the Interaction of Activin-A with Follistatin,” The Journal of Biological Chemistry, 267(7):4999-5004 (1992).
Ikenoue et al., “Inhibitory Effects of Activin-A on Osteoblast Differentiatin During Cultures of Fetal Rat Calvarial Cells,” Journal of Cellular Biochemistry, 75:206-214 (1999).
Journal of Bone and Mineral Research 2006 Abstracts, 21(1):s1-s530 (2006).
Knight, “Roles of Inhibins, Activins, and Follistatin in the Female Reproductive System,” Frontiers in Neuroendocrinology, 17:476-509 (1996).
Koseki, et al., “Role of TCF-β Family in Osteoclastogenesis Induced by RANKL,” Cellular Signaling, 14:31-36 (2002).
Lee et al., “Regulation of Muscle Growth by Multiple Ligands Signaling Through Activin Type II Receptors,” PNAS 102(50):18117-18122 (2005).
Lee, et al., “Regulation of Myostatin Activity and Muscle Growth,” PNAS, 98(16):9306-9311 (2001).
Leto et al., “Activin A Circulating Levels in Patients with Bone Metastasis from Breast or Prostate Cancer,” Clin Exp Metastasis, 23(2):117-122 (2006).
Meriggiola et al., “Follistatin Decreases Activin-Stimulated FSH Secretion with No Effect On GnRH-Stimulated FSH Secretion in Prepubertal Male Monkeys,” Endocrinology, 134(4): 1967-1970 (1994).
Murase et al., “Possible Involvement of Protein Kinases and Smad2 Signaling Pathways on Osteoclast Differentiation Enhanced by Activin A,” Journal of Cellular Physiology, 188:236-242 (2001).
Nagamine et al., “Immunohistochemical Detection of Activin A, Follistatin, and Activin Receptors during Fracture Healing in the Rat,” Journal of Orthopaedic Research, 16:314-321 (1998).
Ogawa et al., “Bovine Bone Activin Enhances Bone Morphogenetic Protein-Induced Ectopic Bone Formation,” The Journal of Biological Chemistry, 267(20):14233-14237 (1992).
Oue et al., “Effect of Local Injection of Activin A on Bone Formation in Newborn Rats,” Bone, 15(3):361-366 (1994).
Rebbapragada et al., “Myostatin Signals Through a Transforming Growth Fact β-Like Signaling Pathway To Block Adipogenesis,” Molecular and Cellular Biology, 23(20):7230-7242 (2003).
Sakai et al., “Activin Enhances Osteoclast-Like Cell Formation in Vitro,” Biochemical and Biophysical Research Communications, 195(1):39-46 (1993).
Sakai et al., “Activin Increases Bone Mass and Mechanical Strength of Lumbar Vertebrae in Aged Ovariectomized Rats,” Bone, 27(1):91-96 (2000).
Sakai et al., “Activin Release From Bone Coupled to Bone Resorption in Organ Culture of Neonatal Mouse Calvaria,” Bone, 26(3):235-240 (2000).
Sakai et al., “Involvement of Activin in the Regulation of Bone Metabolism,” Molecular and Cellular Endocrinology, 180:183-188 (2001).
Sakai et al., “Local Administration of Activin Promotes Fracture Healing in the Rat Fibula Fracture Model,” Bone, 25(2):191-196 (1999).
Sakai, et al., “Osteogenic Activity of Activin in Young Normal Rats and Young Adult and Aged Rats after Ovarlectomy,” Bone, 23:(Suppl.) 467 (1998).
Shuto et al., “Osteoblasts Express Types I and II Activin Receptors During Early Intramembranous and Endochondral Bone Formation,” Journal of Bone Mineral Research, 12(3):403-411 (1997).
Springer, et al., “Seventh European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis,” Osteoporosis International, 18(1):S29-S75 (2007).
Sun et al., “FSH Directly Regulates Bone Mass,” Cell, 125:247-260 (2006).
The Official Journal of the European Calcified Tissue Society, 34th Europena Symposium on Calcified Tissues, May 2007.
Wiater, et al., “Inhibin is an Antagonist of Bone Morphogenetic Protein Signaling,” The Journal of Biological Chemistry, 278(10):7934-7941 (2003).
Elisabetta del Re et al., “Reconstitution and Analysis of Soluble Inhibin and Activin Receptor Complexes in a Cell-free System,” The Journal of Biological Chemistry, 279(51):53126-53135 (2004).
Donaldson et al., “Molecular Cloning and Binding Properties of the Human Type II Activin Receptor,” Biochemical and Biophysical Research Corporation, 184(1):310-316 (1992).
Gray et al., “Identification of a Binding Site on the Type II Activin Receptor for Activin and Inhibin,” The Journal of Biological Chemistry, 275(5):3206-3212 (2000).
Thompson et al., “Structures of an ActRIIB:Activin A Complex Reveal a Novel Binding Mode for TGF-beta Ligand:Receptor Interactions,” EMBO J. 22(7): 1555-1566 (2003).
Hemmati-Brivanlou, A., et al., “A truncated activin receptor inhibits mesoderm induction and formation of axial structures in Xenopus embryos,” Nature, 359:609-614 (1992).
Matzuk et al., “Different phenotypes for mice deficient in either activins or activin receptor type II,” Nature, 374:356-360 (1995).
McNally, E.M., “Powerful Genes—Myostatin Regulation of Human Muscle Mass,” N. Engl. J. Med., 350(26):2642-2644 (2004).
McPherron, A.C., et al., “Regulation of Skeletal Muscle Mass in Mice by a Bew TGF-b Superfamily Member,” Nature, 387:83-90 (1997).
Oh, S.P., et al., “Activin type IIA and IIB receptors mediate Gdf11 signaling in axial v
Knopf John
Seehra Jasbir
Acceleron Pharma Inc.
Chandra Gyan
Landsman Robert
Ropes & Gray LLP
LandOfFree
Isolated activin-binding ActRIIa polypeptide comprising the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated activin-binding ActRIIa polypeptide comprising the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated activin-binding ActRIIa polypeptide comprising the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4094627